178 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
effect to the addbacks set forth in this clause (iii) and clauses (iv) and (xiii) below),
(iv) one-time non-recurring severance, retention … owned or being purchased by such Person (including indebtedness arising under conditional sales or other title retention agreements), whether
8-K
EX-10.1
o1h 1tlbgmvtl8zerb
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
S-3ASR
EX-1.2
t0s6hydwyfk
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-4.3
fq5rlcy0d0wu yupq8au
30 Sep 22
Automatic shelf registration
4:17pm
425
b6g8vgeu6mhuo xy
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-10.1
c29ev3417182fk
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
jeqip36b
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
q1vog0b692
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
2ow18z a5k
3 Dec 20
Other Events
12:00am